Equity

12 Months Ended

Dec. 31, 2020

The following table provides a summary of changes to accumulated other comprehensive income by component for the years ended December 31, 2020 and 2019. During the year ended December 31, 2020, we recognized net unrealized losses of $2 million on our Level 3 AFS securities which we owned as of December 31, 2020.

Table 17.1 – Changes in Accumulated Other Comprehensive Income (Loss) by Component


	Years Ended December 31,
	2020				2019
(In Thousands)	Net Unrealized Gains on Available-for-Sale Securities		Net Unrealized Losses on Interest Rate Agreements Accounted for as Cash Flow Hedges		Net Unrealized Gains on Available-for-Sale Securities		Net Unrealized Losses on Interest Rate Agreements Accounted for as Cash Flow Hedges
Balance at beginning of period	$	92,452	$	(50,939)	$	95,342	$	(34,045)
Other comprehensive (loss) income before reclassifications	(3,951)		(32,806)		17,077		(16,894)
Amounts reclassified from other accumulated comprehensive (loss) income	(12,165)		3,188		(19,967)		—
Net current-period other comprehensive loss	(16,116)		(29,618)		(2,890)		(16,894)
Balance at End of Period	$	76,336	$	(80,557)	$	92,452	$	(50,939)

The following table provides a summary of reclassifications out of accumulated other comprehensive income for the years ended December 31, 2020 and 2019.

Table 17.2 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)



		Amount Reclassified From Accumulated Other Comprehensive Income
	Affected Line Item in the	Year Ended December 31,
(In Thousands)	Income Statement	2020		2019
Net Realized (Gain) Loss on AFS Securities
Credit loss expense on AFS securities	Investment fair value changes, net	$	388	$	—
Gain on sale of AFS securities	Realized gains, net	(12,553)		(19,967)

		$	(12,165)	$	(19,967)
Net Realized Loss on Interest Rate Agreements Designated as Cash Flow Hedges
Amortization of deferred loss	Interest expense	$	3,188	$	—
		$	3,188	$	—

Issuance of Common Stock

In 2018, we established a program to sell up to an aggregate of $150 million of common stock from time to time in at-the-market ("ATM") offerings. In March 2020, we increased the maximum aggregate amount of common stock offered under the ATM program to $175 million. During the year ended December 31, 2020, we issued 129,500 common shares for net proceeds of approximately $2 million through ATM offerings. During the year ended December 31, 2019, we issued 2,259,758 common shares for net proceeds of approximately $36 million through ATM offerings. At December 31, 2020, approximately $110 million remained outstanding for future offerings under this program.

Direct Stock Purchase and Dividend Reinvestment Plan

During the year ended December 31, 2020, we did not issue any shares of common stock through our Direct Stock Purchase and Dividend Reinvestment Plan. During the year ended December 31, 2019, we issued 399,838 shares of common stock through our Direct Stock Purchase and Dividend Reinvestment Plan, resulting in net proceeds of approximately $6 million.

Earnings per Common Share

The following table provides the basic and diluted earnings per common share computations for the years ended December 31, 2020, 2019, and 2018.

Table 17.3 – Basic and Diluted Earnings per Common Share


	Years Ended December 31,
(In Thousands, except Share Data)	2020		2019		2018
Basic (Loss) Earnings per Common Share:
Net (loss) income attributable to Redwood	$	(581,847)	$	169,183	$	119,600
Less: Dividends and undistributed earnings allocated to participating securities	(1,990)		(4,797)		(3,754)
Net (loss) income allocated to common shareholders	$	(583,837)	$	164,386	$	115,846
Basic weighted average common shares outstanding	113,935,605		101,120,744		78,724,912
Basic (Loss) Earnings per Common Share	$	(5.12)	$	1.63	$	1.47
Diluted (Loss) Earnings per Common Share:
Net (loss) income attributable to Redwood	$	(581,847)	$	169,183	$	119,600
Less: Dividends and undistributed earnings allocated to participating securities	(1,990)		(5,273)		(4,283)
Adjust for interest expense and gain on extinguishment of convertible notes for the period, net of tax	—		36,212		32,653
Net (loss) income allocated to common shareholders	$	(583,837)	$	200,122	$	147,970
Weighted average common shares outstanding	113,935,605		101,147,225		78,724,912
Net effect of dilutive equity awards	—		251,100		189,120
Net effect of assumed convertible notes conversion to common shares	—		35,382,269		31,113,738
Diluted weighted average common shares outstanding	113,935,605		136,780,594		110,027,770
Diluted (Loss) Earnings per Common Share	$	(5.12)	$	1.46	$	1.34

We included participating securities, which are certain equity awards that have non-forfeitable dividend participation rights, in the calculations of basic and diluted earnings per common share as we determined that the two-class method was more dilutive than the alternative treasury stock method for these shares. Dividends and undistributed earnings allocated to participating securities under the basic and diluted earnings per share calculations require specific shares to be included that may differ in certain circumstances.

During the years ended December 31, 2019 and 2018, certain of our convertible notes were determined to be dilutive and were included in the calculation of diluted EPS under the "if-converted" method. Under this method, the periodic interest expense (net of applicable taxes) for dilutive notes is added back to the numerator and the weighted average number of shares that the notes are entitled to (if converted, regardless of whether they are in or out of the money) are included in the denominator.

For the year ended December 31, 2020, 31,306,089 of common shares related to the assumed conversion of our convertible notes were antidilutive and were excluded in the calculation of diluted earnings per share.

For the years ended December 31, 2020, 2019, and 2018, the number of outstanding equity awards that were antidilutive totaled 12,622, 10,051, and 7,230, respectively.

Stock Repurchases

In February 2018, our Board of Directors approved an authorization for the repurchase of our common stock, increasing the total amount authorized for repurchases of common stock to $100 million, and also authorized the repurchase of outstanding debt securities, including convertible and exchangeable debt. This authorization increased the previous share repurchase authorization approved in February 2016 and has no expiration date. This repurchase authorization does not obligate us to acquire any specific number of shares or securities. Under this authorization, shares or securities may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. During the year ended December 31, 2020, we repurchased 3,047,335 shares of our common stock pursuant to this authorization for $22 million. At December 31, 2020, $78 million of the current authorization remained available for the repurchase of shares of our common stock and we also continued to be authorized to repurchase outstanding debt securities.